{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:51:17Z","timestamp":1785858677875,"version":"3.56.0"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1097\/01.all.0000191241.66373.74","type":"journal-article","created":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T04:00:55Z","timestamp":1130817655000},"page":"513-518","source":"Crossref","is-referenced-by-count":33,"title":["The range of defects associated with nuclear factor \u03baB essential modulator"],"prefix":"10.1097","volume":"5","author":[{"given":"Gulbu","family":"Uzel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210128","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S1471-4914(01)02154-2","article-title":"NEMO\/IKK gamma: linking NF-kappa B to human disease","volume":"7","author":"Courtois","year":"2001","journal-title":"Trends Mol Med"},{"key":"R2-7-20210128","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1093\/hmg\/11.20.2371","article-title":"The NF-kappaB signalling pathway in human diseases: from incontinentia pigmenti to ectodermal dysplasias and immune-deficiency syndromes","volume":"11","author":"Smahi","year":"2002","journal-title":"Hum Mol Genet"},{"key":"R3-7-20210128","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0092-8674(88)90382-0","article-title":"Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-kappa B transcription factor","volume":"53","author":"Baeuerle","year":"1988","journal-title":"Cell"},{"key":"R4-7-20210128","doi-asserted-by":"crossref","first-page":"5530","DOI":"10.1093\/emboj\/cdg534","article-title":"Genetic analysis of NF-kappaB\/Rel transcription factors defines functional specificities","volume":"22","author":"Hoffmann","year":"2003","journal-title":"EMBO J"},{"key":"R5-7-20210128","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.0105-2896.2005.00221.x","article-title":"Human disease resulting from gene mutations that interfere with appropriate nuclear factor-kappaB activation","volume":"203","author":"Orange","year":"2005","journal-title":"Immunol Rev"},{"key":"R6-7-20210128","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev.immunol.18.1.621","article-title":"Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity","volume":"18","author":"Karin","year":"2000","journal-title":"Annu Rev Immunol"},{"key":"R7-7-20210128","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0962-8924(00)01729-3","article-title":"The IKK complex: an integrator of all signals that activate NF-kappaB?","volume":"10","author":"Israel","year":"2000","journal-title":"Trends Cell Biol"},{"key":"R8-7-20210128","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/26261","article-title":"IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex","volume":"395","author":"Rothwarf","year":"1998","journal-title":"Nature"},{"key":"R9-7-20210128","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S1097-2765(00)80263-4","article-title":"NEMO\/IKK gamma-deficient mice model incontinentia pigmenti","volume":"5","author":"Schmidt-Supprian","year":"2000","journal-title":"Mol Cell"},{"key":"R10-7-20210128","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S1097-2765(00)80262-2","article-title":"Female mice heterozygous for IKK gamma\/NEMO deficiencies develop a dermatopathy similar to the human X-linked disorder incontinentia pigmenti","volume":"5","author":"Makris","year":"2000","journal-title":"Mol Cell"},{"issue":"58","key":"R11-7-20210128","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1126\/stke.2000.58.pe1","article-title":"NF-kappa B defects in humans: the NEMO\/incontinentia pigmenti connection.","volume":"2000","author":"Courtois","year":"2000","journal-title":"Sci STKE"},{"key":"R12-7-20210128","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1086\/316914","article-title":"A novel X-linked disorder of immune deficiency and hypohidrotic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutations in IKK-gamma (NEMO)","volume":"67","author":"Zonana","year":"2000","journal-title":"Am J Hum Genet"},{"key":"R13-7-20210128","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/85837","article-title":"X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling","volume":"27","author":"Doffinger","year":"2001","journal-title":"Nat Genet"},{"key":"R14-7-20210128","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1172\/JCI21345","article-title":"Specific NEMO mutations impair CD40-mediated c-Rel activation and B cell terminal differentiation","volume":"114","author":"Jain","year":"2004","journal-title":"J Clin Invest"},{"key":"R15-7-20210128","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/85277","article-title":"Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia","volume":"2","author":"Jain","year":"2001","journal-title":"Nat Immunol"},{"key":"R16-7-20210128","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jaci.2004.01.762","article-title":"The presentation and natural history of immunodeficiency caused by nuclear factor kappaB essential modulator mutation","volume":"113","author":"Orange","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"R17-7-20210128","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.jaci.2004.06.052","article-title":"Human nuclear factor kappa B essential modulator mutation can result in immunodeficiency without ectodermal dysplasia","volume":"114","author":"Orange","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"R18-7-20210128","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.coi.2003.11.013","article-title":"Inherited disorders of NF-kappaB-mediated immunity in man","volume":"16","author":"Puel","year":"2004","journal-title":"Curr Opin Immunol"},{"key":"R19-7-20210128","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1203\/01.PDR.0000139318.65842.4A","article-title":"The hyper IgM syndrome \u2013 an evolving story","volume":"56","author":"Etzioni","year":"2004","journal-title":"Pediatr Res"},{"key":"R20-7-20210128","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.tube.2004.09.011","article-title":"Control of human host immunity to mycobacteria","volume":"85","author":"Ottenhoff","year":"2005","journal-title":"Tuberculosis (Edinb)"},{"key":"R21-7-20210128","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.jaad.2004.05.032","article-title":"Characteristics of mycobacterial infection in patients with immunodeficiency and nuclear factor-kappaB essential modulator mutation, with or without ectodermal dysplasia","volume":"51","author":"Dai","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"R22-7-20210128","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00008480-200402000-00003","article-title":"Congenital defects in the interferon-gamma\/interleukin-12 pathway","volume":"16","author":"Rosenzweig","year":"2004","journal-title":"Curr Opin Pediatr"},{"key":"R23-7-20210128","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.jaci.2004.08.047","article-title":"Nuclear factor kappaB essential modulator-deficient child with immunodeficiency yet without anhidrotic ectodermal dysplasia","volume":"114","author":"Niehues","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"R24-7-20210128","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1172\/JCI0214858","article-title":"Deficient natural killer cell cytotoxicity in patients with IKK-gamma\/NEMO mutations","volume":"109","author":"Orange","year":"2002","journal-title":"J Clin Invest"},{"key":"R25-7-20210128","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1182\/blood-2003-10-3655","article-title":"X-linked ectodermal dysplasia and immunodeficiency caused by reversion mosaicism of NEMO reveals a critical role for NEMO in human T-cell development and\/or survival","volume":"103","author":"Nishikomori","year":"2004","journal-title":"Blood"},{"key":"R26-7-20210128","first-page":"1345","article-title":"Incontinentia pigmenti. A rare disease with many symptoms [in Swedish]","volume":"99","author":"Holmstrom","year":"2002","journal-title":"Lakartidningen"},{"key":"R27-7-20210128","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1093\/hmg\/ddh192","article-title":"Molecular analysis of the genetic defect in a large cohort of IP patients and identification of novel NEMO mutations interfering with NF-kappaB activation","volume":"13","author":"Fusco","year":"2004","journal-title":"Hum Mol Genet"},{"key":"R28-7-20210128","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/35013114","article-title":"Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium","volume":"405","author":"Smahi","year":"2000","journal-title":"Nature"},{"key":"R29-7-20210128","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1093\/hmg\/10.19.2171","article-title":"A recurrent deletion in the ubiquitously expressed NEMO (IKK-gamma) gene accounts for the vast majority of incontinentia pigmenti mutations","volume":"10","author":"Aradhya","year":"2001","journal-title":"Hum Mol Genet"},{"key":"R30-7-20210128","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1093\/hmg\/10.22.2557","article-title":"Multiple pathogenic and benign genomic rearrangements occur at a 35 kb duplication involving the NEMO and LAGE2 genes","volume":"10","author":"Aradhya","year":"2001","journal-title":"Hum Mol Genet"},{"key":"R31-7-20210128","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1093\/hmg\/5.11.1777","article-title":"Selection against mutant alleles in blood leukocytes is a consistent feature in Incontinentia Pigmenti type 2","volume":"5","author":"Parrish","year":"1996","journal-title":"Hum Mol Genet"},{"key":"R32-7-20210128","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1172\/JCI18714","article-title":"A hypermorphic IkappaBalpha mutation is associated with autosomal dominant anhidrotic ectodermal dysplasia and T cell immunodeficiency","volume":"112","author":"Courtois","year":"2003","journal-title":"J Clin Invest"},{"key":"R33-7-20210128","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1172\/JCI19960","article-title":"Finding NEMO: genetic disorders of NF-[kappa]B activation","volume":"112","author":"Orange","year":"2003","journal-title":"J Clin Invest"}],"container-title":["Current Opinion in Allergy &amp; Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00003072-200511000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:55:26Z","timestamp":1785855326000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00130832-200512000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.1097\/01.all.0000191241.66373.74","relation":{},"ISSN":["1528-4050"],"issn-type":[{"value":"1528-4050","type":"print"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}